Literature DB >> 8555702

Familial non-multiple endocrine neoplasia medullary thyroid carcinoma: report of a case confirming a new clinical entity in Japan.

M Katagiri1, T Ohtawa, K Ito, T Harada.   

Abstract

Most hereditary medullary thyroid carcinomas (MTC) occur in association with multiple endocrine neoplasia (MEN) type 2 syndromes. Since Farndon et al. reported two kindreds, that is collections of relatives, with familial non-MEN MTC in 1986, only five kindreds with this disorder have been reported in the English literature. In this paper, we describe a rare Japanese kindred with familial non-MEN MTC, confirming the existence of this distinct clinical entity in Japan. A 42-year-old woman underwent a left hemithyroidectomy with modified neck dissection (MND) under a diagnosis of sporadic MTC at 28 years of age. She developed lymph node metastasis in the right neck region 7 years after the initial surgery, and underwent MND and right hemithyroidectomy. Although no findings of MTC were histologically confirmed in the resected right thyroid lobe, C-cell hyperplasia was observed. Hereditary MTC was strongly suspected, but we could not confirm specific manifestations associated with MEN type 2 in any family members. However, 7 years later, a paternal aunt and cousin were diagnosed with MTC. Other family members were evaluated by ultrasonography and calcium-pentagastrin provocation testing, and three additional patients with MTC across two generations were found. None of these patients had any extrathyroidal manifestations associated with MEN type 2, and the entity of familial non-MEN MTC was confirmed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8555702     DOI: 10.1007/bf00311460

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Detection of medullary thyroid cancer by calcitonin assay in families.

Authors:  C E Jackson; A H Tashjian; M A Block
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

2.  Multiple endocrine neoplasia type 2 syndromes in Japan.

Authors:  S Takai; A Miyauchi; H Matsumoto; T Ikeuchi; T Miki; K Kuma; Y Kumahara
Journal:  Henry Ford Hosp Med J       Date:  1984

3.  Mixed medullary-follicular carcinoma of the thyroid occurring in familial form.

Authors:  Y Mizukami; T Michigishi; A Nonomura; S Nakamura; M Noguchi; T Hashimoto; N Itoh
Journal:  Histopathology       Date:  1993-03       Impact factor: 5.087

4.  Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy.

Authors:  Q Y Duh; J J Sancho; F S Greenspan; T K Hunt; M Galante; A A deLorimier; F A Conte; O H Clark
Journal:  Arch Surg       Date:  1989-10

5.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

Authors:  H Donis-Keller; S Dou; D Chi; K M Carlson; K Toshima; T C Lairmore; J R Howe; J F Moley; P Goodfellow; S A Wells
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

7.  Family members of patients with sporadic medullary thyroid carcinoma must be screened for hereditary disease.

Authors:  J E Olson; J Hughes; H D Alpern
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

8.  Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity.

Authors:  J R Farndon; G S Leight; W G Dilley; S B Baylin; R C Smallridge; T S Harrison; S A Wells
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

9.  Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.

Authors:  C R McHenry; D S Oppenheim; T Murphy; T Broughan; D Vogt; W B Goldfarb
Journal:  Surgery       Date:  1992-10       Impact factor: 3.982

10.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.

Authors:  R M Hofstra; R M Landsvater; I Ceccherini; R P Stulp; T Stelwagen; Y Luo; B Pasini; J W Höppener; H K van Amstel; G Romeo
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.